➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Harvard Business School
Boehringer Ingelheim
Dow
Johnson and Johnson
Moodys

Last Updated: October 26, 2021

DrugPatentWatch Database Preview

Maia Pharms Inc Company Profile


Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for MAIA PHARMS INC, and what generic and branded alternatives to MAIA PHARMS INC drugs are available?

MAIA PHARMS INC has seven approved drugs.



Summary for Maia Pharms Inc
US Patents:0
Tradenames:4
Ingredients:4
NDAs:7

Drugs and US Patents for Maia Pharms Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Maia Pharms Inc BACLOFEN baclofen INJECTABLE;INTRATHECAL 210048-001 Sep 11, 2019 AP RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial
Maia Pharms Inc LEVOTHYROXINE SODIUM levothyroxine sodium POWDER;INTRAVENOUS 208749-001 Dec 21, 2018 AP RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial
Maia Pharms Inc SODIUM PHENYLACETATE AND SODIUM BENZOATE sodium benzoate; sodium phenylacetate SOLUTION;INTRAVENOUS 215025-001 Jun 10, 2021 RX Yes Yes ⤷  Free Forever Trial ⤷  Free Forever Trial
Maia Pharms Inc LEVOTHYROXINE SODIUM levothyroxine sodium POWDER;INTRAVENOUS 208749-002 Dec 21, 2018 AP RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial
Maia Pharms Inc SODIUM PHENYLACETATE AND SODIUM BENZOATE sodium benzoate; sodium phenylacetate SOLUTION;INTRAVENOUS 208521-001 May 8, 2017 AP RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial
Maia Pharms Inc BACLOFEN baclofen INJECTABLE;INTRATHECAL 210315-001 Jul 30, 2019 AP RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial
Maia Pharms Inc ANGIOMAX RTU bivalirudin SOLUTION;INTRAVENOUS 211215-001 Jul 25, 2019 RX Yes Yes ⤷  Free Forever Trial ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Paragraph IV (Patent) Challenges for MAIA PHARMS INC drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe for Injection 100 mcg/vial and 500 mcg/vial ➤ Subscribe 2015-04-14
➤ Subscribe for Injection 200 mcg/vial ➤ Subscribe 2015-05-01
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
McKinsey
McKesson
Baxter
Express Scripts
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.